Celiac disease (CD) is most probably an immunological disease, precipitated in susceptible individuals by ingestion of wheat gliadin and related proteins from other cereals. The disease shows a strong human HLA association predominantly to the cis or trans encoded HLA-DQ(alpha 1*0501,beta 1*0201) (DQ2) heterodimer. T cell recognition of gliadin presented by this DQ heterodimer may thus be of immunopathogenic importance in CD. We therefore challenged small intestinal biopsies from adult CD patients on a gluten-free diet in vitro with gluten (containing both gliadin and other wheat proteins), and isolated activated CD25+ T cells. Polyclonal T cell lines and a panel of T cell clones recognizing gluten were established. They recognized the gliadin moiety of gluten, but not proteins from other cereals. Inhibition studies with anti-HLA antibodies demonstrated predominant antigen presentation by HLA-DQ molecules. The main antigen-presenting molecule was established to be the CD-associated DQ(alpha 1*0501, beta 1*0201) heterodimer. The gluten-reactive T cell clones were CD4+, CD8-, and carried diverse combinations of T cell receptor (TCR) V alpha and V beta chains. The findings suggest preferential mucosal presentation of gluten-derived peptides by HLA-DQ(alpha 1*0501, beta 1*0201) in CD, which may explain the HLA association.
Skip Nav Destination
Article navigation
1 July 1993
Article|
July 01 1993
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
K E Lundin,
K E Lundin
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
H Scott,
H Scott
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
T Hansen,
T Hansen
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
G Paulsen,
G Paulsen
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
T S Halstensen,
T S Halstensen
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
O Fausa,
O Fausa
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
E Thorsby,
E Thorsby
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
L M Sollid
L M Sollid
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Search for other works by this author on:
K E Lundin
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
H Scott
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
T Hansen
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
G Paulsen
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
T S Halstensen
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
O Fausa
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
E Thorsby
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
L M Sollid
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1993) 178 (1): 187–196.
Citation
K E Lundin, H Scott, T Hansen, G Paulsen, T S Halstensen, O Fausa, E Thorsby, L M Sollid; Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.. J Exp Med 1 July 1993; 178 (1): 187–196. doi: https://doi.org/10.1084/jem.178.1.187
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement